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Abstract
Introduction: Synovial sarcoma is a rare malignant mesenchymal tumor mainly arising in the peri-articular tissue in
young adults. There are few cases reported in other areas.
Case presentation: We report the case of a 29-year-old Saudi woman of Arabian ethnicity with synovial sarcoma
arising primarily from the ileum who presented with abdominal pain, a palpable mass and incomplete intestinal
obstruction. A literature review was performed to gather information on this rare gastrointestinal tract sarcoma.
Conclusions: Although it is a rare tumor of the pre-articular tissues, synovial sarcoma can present, in exceedingly
rare cases, in unusual anatomical sites such as the gastrointestinal tract. We believe the reporting of all rare or
unexpected presentations of sarcoma will eventually improve our understanding of this relatively unusual
malignancy.
Introduction
Synovial sarcoma is a malignant mesenchymal tumor of
uncertain histogenesis. It may be biphasic, monophasic,
or poorly differentiated [1]. Synovial sarcoma is a rare
entity representing 5% to 10% of all soft tissue sarcomas,
typically occurring around the joints, mainly the knee
[2,3]. Occasionally, it arises in the head and neck [4,5],
lungs [6-8], heart [9], retroperitoneum [10], prostate
[11] and intra-neurally [12]. There are few cases
reported of synovial sarcoma arising in the gastrointest-
inal tract. We report the case of primary synovial sar-
coma arising in the ileum of a 29-year-old woman. Our
patient’s tumor displayed morphologic features and
immunohistochemical staining consistent with this dis-
ease. We believe that our case is the first reported case
of monophasic synovial sarcoma arising from the ileum.
Case presentation
A 29-year-old Saudi woman presented to our Emer-
g e n c yR o o mw i t haf i v e - d a yh i s t o r yo fe p i g a s t r i ca n d
lower abdominal pain associated with lower abdominal
and pelvic fullness that she attributed to fibroids. The
pain was intermittent, colicky in nature and associated
with nausea and vomiting. S h ed e n i e da n yh i s t o r yo f
fever and there had been no change in her bowel habits
or urinary symptoms. For several months she had been
followed up regularly at the gynecology clinic due to the
lower abdominal heaviness and distension. Her gyneco-
logical history revealed a nulliparous woman with no
vaginal bleeding. Her medical history was significant for
epilepsy since childhood, which was well controlled by
medication, and a laparoscopic appendectomy one year
ago. On examination, she was alert and conscious. Her
vital signs were stable. Her abdomen was distended with
a palpable pelvic-abdominal mass that was hard, non-
tender and slightly mobile. Her liver and spleen were
within the normal range and she had normal bowel
sounds. No lymph nodes were enlarged and digital rec-
tal examination revealed no abnormalities.
A computed tomography (CT) scan of her abdomen
and pelvis showed a pelvic/abdominal mass adjacent to
the distal small bowel loops separate from the uterus
and ovaries, heterogeneously enhancing, measuring
roughly 65 × 99 mm with multiple areas of necrosis
(Figure 1A, B). A CT scan of her chest showed indeter-
minate multiple bilateral subpleural 2 mm to 4 mm
lung nodules, too small to biopsy.
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board and the advice was to confirm the diagnosis to
eliminate the possibility of an ovarian origin of the
tumor because of its very close proximity.
Surgical exploration was indicated due to the finding
of a large mass that was composed of a cystic and also a
large solid component that needed to be investigated to
eliminate the possibility of lymphoma or tuberculosis,
which is quite common in our population. However,
there was some radiological confusion about the origin
of this mass and to some colleagues it was necessary to
confirm it with a histological biopsy. For this reason,
our patient underwent diagnostic laparoscopy, which
showed a moderate amount of ascetic fluid with a large
mass in the lower abdomen. When a biopsy was
attempted, a large vein on the mass ruptured and bleed-
ing made visualization extremely difficult. Therefore, the
procedure was converted to an open one through a
small lower midline incision. A 10 × 10 cm mass arising
from the terminal ileum, occupying the pelvis and
reaching to the umbilical area was found.
The uterus, ovaries and the urinary bladder were not
involved. After a minimal dissection the tumor was
excised with 10 cm free margins of small bowel and pri-
mary side-to-side anastomosis was performed. Our
patient tolerated the procedure very well and her recov-
ery period was unremarkable. She was discharged home
on the seventh post-operative day. She was reviewed on
an out-patient basis by our colleagues in radio-oncology
and due to the radical nature of the surgery she was not
offered any adjuvant treatment. She is still being fol-
lowed up by our surgical oncology team and has shown
no evidence of local or distant metastasis based on clini-
cal and CT scan results after 24 months of follow-up.
Gross pathology revealed a segment of small bowel mea-
suring 17 × 2 cm. It was adherent to a portion of ascend-
ing colon. An 8 × 7 × 3 cm white solid mass with a
homogeneous cut surface was bulging from the serosal
side of the small bowel; it was 4 cm away from the proxi-
mal resection margin. The tumor was adherent to the
large bowel but not infiltrating it grossly. Few lymph
nodes were identified within the mesenteric fat. Micro-
scopy showed that the tumor was composed of cellular
spindle cells with a mild to moderate degree of pleo-
morphism arising from the small bowel wall and mainly
involving the submucosa, muscularis propria and serosa.
Focal mucosal erosion was identified. The tumor cells
showed a moderate amount of eosinophilic cytoplasm,
evenly distributed nuclear chromatin and a few conspicu-
ous nuclei (Figure 2A, B). The mitotic count was one to
two per 10 high-power fields. A metastatic focus was iden-
tified within a single mesenteric lymph node (Figure 2C).
Immunohistochemical testing results showed that the
tumor was positive for S100, epithelial membrane anti-
gen (EMA), B cell lymphoma 2 (Bcl 2), and vimentin
(Figure 3A-C). CD99 tests were negative (Figure 3F) and
Figure 1 (A, B) Computed tomography (CT) axial and coronal cuts showing the pelvic/abdominal heterogeneous mass with areas of
necrosis in addition to ascites.
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retinin (focal) and synaptophysin (focal), and CD56 (few
cells). The specimen tested negative for CD34, CAM5.2,
cytokeratin 7, 20, and 5/6 (Figure 3H), cytokeratin AE1/
AE3, neuron-specific enolase (NSE), CD31, desmin (Fig-
ure 3G), chromogranin, smooth muscle actin (SMA),
HMB45, factor 8, Ber/EB4, and melan-A.
A cytogenetic study of the specimen was conducted on a
formalin fixed paraffin embedded tumor sample. The
result of a real-time polymerase chain reaction (RT-PCR)
procedure for synovial sarcoma-associated fusion tran-
script (SYT-SSX1 and SYT-SSX2) was negative.
Our patient was seen periodically in our surgical
oncology clinic and she has remained disease free for 24
months with no clinical or radiological evidence of local
recurrence.
Discussion
Gastrointestinal sarcoma accounts for 0.1% to 3% of all
gastrointestinal (GI) malignancies and approximately
10% of all sarcomas [13,14]. In the ileum, the majority
of malignant sarcomas are GI stromal tumors (GISTs)
[15]. To the best of our knowledge there have been only
27 reported cases of synovial sarcoma arising in the GI
tract, and none of them in the ileum [16-32]. All of
them shared the diagnostic histology and immunohisto-
chemical features of synovial sarcoma. In 64% of the
cases, the characteristic (X; 18) translocation was identi-
fied. We made the diagnosis in our patient’s case based
on the histology of monophasic synovial sarcoma and
the Immunohistochemical features. Although the mole-
cular assay results were negative for SYT-SSX1 and
SYT-SSX2, the combined histological and Immunohisto-
chemical profiles were highly characteristic of monopha-
sic synovial sarcoma.
The median age at diagnosis was 41.5 years (range, 14
to 75 years). There is no significant sex predilection
with a male to female ratio of 1:1.15. There are 11 and
12 cases of GI tract synovial sarcoma arising from the
esophagus (including one from the gastroesophageal
junction) and stomach, respectively, representing the
most common sites. The presenting symptoms were
Figure 2 (A) A spindle cell neoplasm arising from the wall of the small bowel and pushing the mucosa toward the lumen, (B) spindle
cells with mild to moderate degree of pleomorphism and few conspicuous nuclei, and (C) a spindle cell metastatic focus in a
mesenteric lymph node (hematoxylin and eosin; (A) ×2, (B) ×20, (C) ×4).
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were monophasic in 15 patients and biphasic in 11
patients including two patients with a poorly differen-
tiated component. The remaining patients’ histological
subtypes have not been reported. All of the reported
cases were treated surgically. The number of patients
who received adjuvant chemotherapy or radiotherapy or
both are five, four and three, respectively. Only one
patient had metastasis at first presentation. Billings [25]
reported a patient with gastric synovial sarcoma with
multiple liver metastases who died of the disease after
six months. The survival period after diagnosis of all
reported cases ranged from 1 to 224 months (Table 1).
In soft tissue synovial sarcoma, numerous studies over
the years have reported that it is a high grade malig-
nancy with a high rate of metastasis leading to death;
Figure 3 Immunohistochemical staining. (A) S100, ×20; (B) epithelial membrane antigen (EMA), ×20; (C) B cell lymphoma 2 (Bcl 2), ×40; (D)
vimentin, ×20; (E) CD117, ×20; (F) CD99, ×20; (G) desmin, ×20; (H) cytokeratin (CK)5/6, ×20.
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Page 4 of 7Table 1 Summary of the reported cases of primary synovial sarcoma in the gastrointestinal tract
Author, year,
reference
Location Presenting
symptoms
Age,
years
Gender Size,
cm
Gross
features
Histologic
type
Translocation Treatment Status and
follow-up,
months
Palmer et al.
1983 [16]
Esophagus Dysphagia 75 F 2.5 Polypoid Biphasic - S+Rad DOD, 24
Amr et al. 1984
[17]
Esophagus Dysphagia 25 M 5 Polypoid Biphasic - S+Rad AWOD, 36
Bloch et al.,
1987 [18]
Esophagus Dysphagia,
dyspnea
15 M 7 Polypoid Biphasic - S+Rad AWOD, 36
Pulpiero et al.,
1988 [19]
Esophagus 24 M Biphasic - S NR
Caldwell et al.,
1991 [20]
Esophagus 29 F NR - S+Rad
+Chemo
AWOD, 195
Perch et al.,
1991 [21]
Esophagus 15 M Biphasic - S+Rad AWOD, 5 to 6
years after
surgery
Antón-Pacheco
et al., 1996 [22]
Esophagus Dysphagia,
weight loss
14 F 7 Polypoid Biphasic - S+Chemo
+Rad
AWOD, 30
Habu S et al.
1998 [23]
Esophagus Sensation of
something
stuck in the
throat
20 M 8 Polypoid Biphasic - S+Chemo
+Rad
AWOD, 20
Bonavina et al.,
1998 [24]
Esophagus Achalasia 63 F Polypoid NR - - -
Billings et al.,
2000 [25]
Gastroesophageal
junction
Incidental
finding for
pyloric
stenosis
47 M 5.2 Polypoid Biphasic t(X; 18) S AWOD, 21
Billings et al.,
2000 [25]
Stomach Abdominal
pain,
nausea,
vomiting
and rectal
bleeding
55 F 16 Spherical,
intramural
Biphasic and
PDSS
t(X; 18) S DOD, 6
Chan et al., 2004
[26]
Jejunum Epigastric
pain,
vomiting
and fever
28 M 15 Polypoid,
intramural
Monophasic t(X; 18), SSX2 S DOD, 1
Butori et al.,
2006 [27]
Esophagus Dysphagia 72 F 11 Polypoid Biphasic t(X; 18) S+Chemo 6
Akhunji et al.,
2007 [28]
Stomach Epigastric
pain
42 M 11 Biphasic t(X; 18) S+Chemo DOD, 24
Parfitt et al.,
2007 [29]
Colon Rectal
bleeding
32 M 2 Polypoid Monophasic t(X; 18) S 5
Schreiber-
Fracklam et al.,
2007 [30]
Distal duodenum Abdominal
pain
39 F 5 Polypoid Monophasic t(X; 18), SSX2 S+Chemo Recurrence 8
months after
surgery
Makhlouf et al.,
2008 [32]
Stomach 67 F 0.8 Monophasic t(X; 18) S AWOD, 12
Makhlouf et al.,
2008 [32]
Stomach 49 M 2 Monophasic
with a poorly
differentiated
component
t(X; 18) S DOD, omental
metastasis, 29
Makhlouf et al.,
2008 [32]
Stomach 68 F 2 Monophasic t(X; 18) S AWOD, 22
Makhlouf et al.,
2008 [32]
Stomach 29 M 2.8 Monophasic t(X; 18) S AWOD, 224
Makhlouf et al.,
2008 [32]
Stomach,
gastrodudenal
junction
54 F 3 Monophasic t(X; 18) S Recent case
Makhlouf et al.,
2008 [32]
Stomach 58 F 3 Monophasic t(X; 18) S AWOD, 21
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56% have been reported [27,33].
In the article by Bergh et al. [33], the investigators
divided patients with synovial sarcoma into low-risk and
high-risk groups depending on their age, tumor size and
grade as follows: low-risk group (patient age < 25 years,
tumor size < 5 cm, and no histologic evidence of poorly
differentiated tumor); high-risk group (patient age
approximately 25 years, tumor size approximately 5 cm,
and poorly differentiated tumor). The question is, can we
apply the same risk factors to patients with GI synovial
sarcoma? To answer such a question we need to diagnose
more cases and collect more data about the already pub-
lished cases to study the behavior of this disease entity in
the GI tract, as well as in other parts of the body. Pre-
sently, the evidence suggests adequate primary surgery is
essential to both local control and outcome. The other
question that one may ask: why do these tumors shift to
unusual sites and different tissues? The honest answer, at
least at this time, would by that we do not yet know the
exact mechanism for such a shift. We are involved in a
larger research study to investigate the increased inci-
dence of sarcomas in the Saudi population, particularly in
the northern region, which is close to the military activ-
ities of both Gulf wars and the military activities in Iraq
over the last decade.
Conclusions
In general, sarcomas are relatively rare tumor entities,
particularly in the GI tract. For many reasons, it is easy
to confuse the subtypes of sarcomas, including the
histological similarities, the experience of the centers
dealing with such tumors, proper handling, and staining
and immunohistochemical findings. It is also likely to
mistake such extremely rare presentations of an unusual
malignancy such as synovial sarcoma for relatively more
common tumors such as GISTs, which can present with
more or less the same clinical scenario. The clinical
importance comes from the fact that sarcomas carry a
slightly worse prognosis and need a closer follow-up not
to miss any sign of local recurrence or distant metasta-
sis. We also believe that any rare presentation of any
subtype of sarcoma should be carefully reported and
documented to add to the relatively small pool of cases
in comparison with other common malignant tumors, in
order to increase our knowledge and understanding of
sarcoma in general.
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Table 1 Summary of the reported cases of primary synovial sarcoma in the gastrointestinal tract (Continued)
Makhlouf et al.,
2008 [32]
Stomach 37 F 4 Monophasic t(X; 18) S Local
recurrence, re-
excised. DOC
48
Makhlouf et al.,
2008 [32]
Stomach 50 M 6 Monophasic t(X; 18) S+Chemo Alive with
recurrence, 6
Makhlouf et al.,
2008 [32]
Stomach 42 M 8 Polypoid Biphasic t(X; 18) S+Chemo DOD, 25
Makhlouf et al.,
2008 [32]
Stomach 66 F 15 Polypoid Monophasic t(X; 18) S Lost to follow-
up
Company et al.,
2009 [31]
Proximal
duodenum
Weight loss
asthenia
anorexia,
nausea,
epigastric
pain
69 F 8 Spherical,
intramural
Monophasic t(X; 18) S Died due to
complications,
1
Present case,
2010
Ileum Abdominal
pain,
distension
and
heaviness
39 F 8 Intramural Monophasic - S AWOD, 6
The second case reported by Billings [25] could represent a metastatic focus of a primary neck tumor as it showed the same histopathological features.
AWOD = alive without evidence of disease; AWD = alive with residual disease; Chemo = chemotherapy; DOC = died of other cause; DOD = died of disease; NR =
not reported; Rad = radiotherapy; S = surgery; SSX = synovial sarcoma-associated fusion transc; PDSS = Poorly difrentiated synovial sarcoma
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